John McPeake – Rosenblatt

Rosenblatt

A Rosenblatt analyst with 4 tracked ratings spanning 4 distinct tickers has achieved an 85.7% success rate on the captured sample, focusing exclusively on one source.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

14 days ago

2026-05-21 00:00:00+00

Track record

Aggregated

86% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 20
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
PLTR	2026-05-21	buy	$225.00	Aggregated
QBTS	2026-05-13	buy	$43.00	Aggregated
PLTR	2026-05-05	buy	$225.00	Aggregated
PLTR	2026-03-25	buy	$200.00	Aggregated
RGTI	2026-03-05	buy	$40.00	Aggregated
PLTR	2026-03-03	buy	$200.00	Aggregated
QUBT	2026-03-03	buy	$22.00	Aggregated
PLTR	2026-02-27	buy	$150.00	Aggregated
IONQ	2026-02-26	buy	$100.00	Aggregated
IONQ	2026-02-06	buy	$100.00	Aggregated
QBTS	2026-01-28	buy	$43.00	Aggregated
IONQ	2026-01-27	buy	$100.00	Aggregated
RGTI	2026-01-21	buy	$40.00	Aggregated
QUBT	2026-01-15	buy	$22.00	Aggregated
RGTI	2026-01-15	buy	$40.00	Aggregated
QBTS	2026-01-08	buy	$43.00	Aggregated
QBTS	2026-01-07	buy	$40.00	Aggregated
QBTS	2025-11-07	buy	$40.00	Aggregated
IONQ	2025-11-06	buy	$100.00	Aggregated
IONQIONQ INC	2025-11-06	unknown	$100.00	Aggregated
SNPSSYNOPSYS, INC.	2021-08-25	unknown	$349.00	Aggregated
PDFS	2021-08-11	buy	$23.00	Aggregated
PDFSPDF SOLUTIONS INC.	2021-08-11	unknown	$23.00	Aggregated
MSFTMICROSOFT CORPORATION	2021-07-28	unknown	$349.00	Aggregated

Tickers covered(10)

Ticker	Ratings	Last rating	Sources
PLTR	5	2026-05-21	Aggregated
QBTS	5	2026-05-13	Aggregated
RGTI	3	2026-03-05	Aggregated
QUBT	2	2026-03-03	Aggregated
IONQ	4	2026-02-26	Aggregated
IONQIONQ INC	1	2025-11-06	Aggregated
SNPSSYNOPSYS, INC.	1	2021-08-25	Aggregated
PDFS	1	2021-08-11	Aggregated
PDFSPDF SOLUTIONS INC.	1	2021-08-11	Aggregated
MSFTMICROSOFT CORPORATION	1	2021-07-28	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.